SEC Form 4 · accession 0001209191-17-006406
ANAPTYSBIO, INC · ANAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James N Topper
Director · 10% Owner
Period of report
Jan 31, 2017
Accepted (ET)
Jan 31, 2017 · 4:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001370053
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 31, 2017 | C | 2,228,377 | $0.00 | A | 2,228,377 | I | see footnote |
| Common StockF1,F3 | Jan 31, 2017 | C | 733,740 | $0.00 | A | 733,740 | I | see footnote |
| Common StockF1,F4 | Jan 31, 2017 | C | 209,095 | $0.00 | A | 209,095 | I | see footnote |
| Common StockF3 | Jan 31, 2017 | P | 311,291 | $15.00 | A | 1,045,031 | I | see footnote |
| Common StockF4 | Jan 31, 2017 | P | 88,709 | $15.00 | A | 297,804 | I | see footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B Preferred StockF2,F1 | $0.00 | Jan 31, 2017 | C | 1,428,571 | D | — | — | Common Stock | 1,428,571 | 0 | I |
| Series C Preferred StockF2,F1 | $0.00 | Jan 31, 2017 | C | 604,055 | D | — | — | Common Stock | 604,055 | 0 | I |
| Series C-1 Preferred StockF2,F1 | $0.00 | Jan 31, 2017 | C | 195,751 | D | — | — | Common Stock | 195,751 | 0 | I |
| Series D Preferred StockF3,F1 | $0.00 | Jan 31, 2017 | C | 733,740 | D | — | — | Common Stock | 733,740 | 0 | I |
| Series D Preferred StockF4,F1 | $0.00 | Jan 31, 2017 | C | 209,095 | D | — | — | Common Stock | 209,095 | 0 | I |
Explanation of responses
- F1In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated.
- F2Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Ventures. Dr. Topper is a General Partner of Frazier Healthcare. Mr. Topper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- F3Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Ventures. Dr. Topper is a General Partner of Frazier Healthcare. Mr. Topper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- F4Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Ventures. Dr. Topper is a General Partner of Frazier Healthcare. Mr. Topper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.